FTSE Russell Analytics

content.title.value
FTSE Russell Analytics

PDF, 456.44KB, 4 pages

Download
Download

Share price analysis relative to sector and index performance.

Company tear sheet

content.image.label
Company tear sheet

PDF, 59.46KB, 7 pages

Download
Download

Full issuer details available in a single file ready for sharing.

HUTCHMED (China) Limited news

Show all news
Sort by
Show 20 news
137 results (20 showing)
HeadlineSourceDateTime
Breakthrough Therapy Designation for Amdizalisib
Reach
13 September 2021
07:00:08
Reach 13.09.21 07:00:08
HUTCHMED and AZ Initiate Phase III Trial in China
Reach
08 September 2021
11:30:00
Reach 08.09.21 11:30:00
HUTCHMED to Present Clinical Data at ESMO
Reach
07 September 2021
09:30:08
Reach 07.09.21 09:30:08
HUTCHMED Shares Included in Stock Connect Programs
Reach
06 September 2021
07:00:08
Reach 06.09.21 07:00:08
Grant of Share Options, and Awards under LTIP
RNS
02 September 2021
12:45:06
RNS 02.09.21 12:45:06
Total Voting Rights
RNS
31 August 2021
09:30:01
RNS 31.08.21 09:30:01
Phase Ib/II Trial of Fruquintinib & Tislelizumab
Reach
26 August 2021
07:00:03
Reach 26.08.21 07:00:03
HUTCHMED Selected for Certain Hang Seng Indexes
Reach
23 August 2021
07:00:06
Reach 23.08.21 07:00:06
ELECTRONIC COMMUNICATION OF CORPORATE INFORMATION
RNS
17 August 2021
09:30:03
RNS 17.08.21 09:30:03
HUTCHMED & Epizyme Announce TAZVERIK Collaboration
RNS
09 August 2021
07:00:07
RNS 09.08.21 07:00:07
Total Voting Rights
RNS
30 July 2021
09:30:06
RNS 30.07.21 09:30:06
Interim Results and Business Updates
RNS
28 July 2021
12:00:01
RNS 28.07.21 12:00:01
Phase II Trial of ORPATHYS Initiated
Reach
28 July 2021
07:00:09
Reach 28.07.21 07:00:09
Stabilizing Actions & End of Stabilization Period
RNS
23 July 2021
12:01:35
RNS 23.07.21 12:01:35
Holding(s) in Company
RNS
16 July 2021
10:50:00
RNS 16.07.21 10:50:00
Surufatinib MAA Submitted and Validated by the EMA
Reach
16 July 2021
07:00:03
Reach 16.07.21 07:00:03
Holding(s) in Company
RNS
14 July 2021
09:35:01
RNS 14.07.21 09:35:01
First Commercial Sale of ORPATHYS® in China
Reach
13 July 2021
07:00:05
Reach 13.07.21 07:00:05
Full Exercise of the Over-allotment Option
RNS
12 July 2021
14:35:02
RNS 12.07.21 14:35:02
HUTCHMED Initiates Phase I Trials of HMPL-295
Reach
06 July 2021
09:30:01
Reach 06.07.21 09:30:01